메뉴 건너뛰기




Volumn 32, Issue 5, 2014, Pages 1278-1288

Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: Correlation of biological markers with clinical responses

Author keywords

Allogeneic stem cell transplantation; Biomarkers; Graft versus host disease; Mesenchymal stromal cell

Indexed keywords

ANTIVIRUS AGENT; BASILIXIMAB; BIOLOGICAL MARKER; CD40 LIGAND; CK18 PROTEIN; CORTICOSTEROID; CYTOKINE; ELAFIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANZYME B; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23P19; INTERLEUKIN 8; MEPREDNISONE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; REG 3ALPHA PROTEIN; SCATTER FACTOR; STEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; CYTOKERATIN 18; LECTIN; PANCREATITIS-ASSOCIATED PROTEIN; TUMOR ANTIGEN; TUMOR MARKER;

EID: 84898996784     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1638     Document Type: Article
Times cited : (82)

References (17)
  • 1
    • 84883375670 scopus 로고    scopus 로고
    • Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem-cell transplantation
    • Jitschin R, Mougiakakos D, Von Bahr L, et al. Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem-cell transplantation. Stem Cells 2013; 31: 1715-1725.
    • (2013) Stem Cells , vol.31 , pp. 1715-1725
    • Jitschin, R.1    Mougiakakos, D.2    Von Bahr, L.3
  • 2
    • 70849132807 scopus 로고    scopus 로고
    • Mesenchymal stem cells in hematopoietic stem cell transplantation
    • Battiwalla M, Hematti P,. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy 2009; 11: 503-515.
    • (2009) Cytotherapy , vol.11 , pp. 503-515
    • Battiwalla, M.1    Hematti, P.2
  • 3
    • 43049103438 scopus 로고    scopus 로고
    • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study
    • Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008; 371: 1579-1586.
    • (2008) Lancet , vol.371 , pp. 1579-1586
    • Le Blanc, K.1    Frassoni, F.2    Ball, L.3
  • 4
    • 2342482526 scopus 로고    scopus 로고
    • Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
    • Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-1441.
    • (2004) Lancet , vol.363 , pp. 1439-1441
    • Le Blanc, K.1    Rasmusson, I.2    Sundberg, B.3
  • 5
    • 79952624644 scopus 로고    scopus 로고
    • Efficacy and safety of ex-vivo cultured adult human mesenchymal stem cells (prochymal(TM)) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study
    • Prasad VK, Lucas KG, Kleiner GI, et al. Efficacy and safety of ex-vivo cultured adult human mesenchymal stem cells (prochymal(TM)) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 2011; 17: 534-541.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 534-541
    • Prasad, V.K.1    Lucas, K.G.2    Kleiner, G.I.3
  • 6
    • 35449007194 scopus 로고    scopus 로고
    • Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
    • Ringden O, Uzunel M, Sundberg B, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007; 21: 2271-2276.
    • (2007) Leukemia , vol.21 , pp. 2271-2276
    • Ringden, O.1    Uzunel, M.2    Sundberg, B.3
  • 7
    • 84873044177 scopus 로고    scopus 로고
    • Discovery and validation of graft-versus-host disease biomarkers
    • Paczesny S,. Discovery and validation of graft-versus-host disease biomarkers. Blood 2013; 121: 585-594.
    • (2013) Blood , vol.121 , pp. 585-594
    • Paczesny, S.1
  • 8
    • 84856584184 scopus 로고    scopus 로고
    • The establishment of a bank of stored clinical bone marrow stromal cell products
    • Sabatino M, Ren J, David-Ocampo V, et al. The establishment of a bank of stored clinical bone marrow stromal cell products. J Transl Med 2013; 10: 23.
    • (2013) J Transl Med , vol.10 , pp. 23
    • Sabatino, M.1    Ren, J.2    David-Ocampo, V.3
  • 9
    • 84863371821 scopus 로고    scopus 로고
    • Plasma biomarkers of lower gastrointestinal and liver acute GVHD
    • Harris AC, Ferrara JL, Braun TM, et al. Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood 2011; 119: 2960-2963.
    • (2011) Blood , vol.119 , pp. 2960-2963
    • Harris, A.C.1    Ferrara, J.L.2    Braun, T.M.3
  • 10
    • 84860345135 scopus 로고    scopus 로고
    • Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: A blood and marrow transplant clinical trials network study
    • Levine JE, Logan BR, Wu J, et al. Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: A blood and marrow transplant clinical trials network study. Blood 2012; 119: 3854-3860.
    • (2012) Blood , vol.119 , pp. 3854-3860
    • Levine, J.E.1    Logan, B.R.2    Wu, J.3
  • 11
    • 84855296444 scopus 로고    scopus 로고
    • Steroid-refractory acute GVHD: Predictors and outcomes
    • Westin JR, Saliba RM, De Lima M, et al. Steroid-refractory acute GVHD: Predictors and outcomes. Adv Hematol 2011; 2011: 601953.
    • (2011) Adv Hematol , vol.2011 , pp. 601953
    • Westin, J.R.1    Saliba, R.M.2    De Lima, M.3
  • 12
    • 84858080480 scopus 로고    scopus 로고
    • Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy
    • von Bahr L, Sundberg B, Lonnies L, et al. Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol Blood Marrow Transplant 2012; 18: 557-564.
    • (2012) Biol Blood Marrow Transplant , vol.18 , pp. 557-564
    • Von Bahr, L.1    Sundberg, B.2    Lonnies, L.3
  • 13
    • 68449086888 scopus 로고    scopus 로고
    • HSCT recipients have specific tolerance to MSC but not to the MSC donor
    • Sundin M, Barrett AJ, Ringden O, et al. HSCT recipients have specific tolerance to MSC but not to the MSC donor. J Immunother 2009; 32: 755-764.
    • (2009) J Immunother , vol.32 , pp. 755-764
    • Sundin, M.1    Barrett, A.J.2    Ringden, O.3
  • 14
    • 84862296213 scopus 로고    scopus 로고
    • Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation
    • Lucchini G, Dander E, Pavan F, et al. Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation. Stem Cells Int 2012; 2012: 690236.
    • (2012) Stem Cells Int , vol.2012 , pp. 690236
    • Lucchini, G.1    Dander, E.2    Pavan, F.3
  • 15
    • 12144288738 scopus 로고    scopus 로고
    • Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis
    • Srinivasan R, Chakrabarti S, Walsh T, et al. Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis. Br J Haematol 2004; 124: 777-786.
    • (2004) Br J Haematol , vol.124 , pp. 777-786
    • Srinivasan, R.1    Chakrabarti, S.2    Walsh, T.3
  • 16
    • 63949085855 scopus 로고    scopus 로고
    • Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial
    • Macmillan ML, Blazar BR, DeFor TE, et al. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant 2009; 43: 447-454.
    • (2009) Bone Marrow Transplant , vol.43 , pp. 447-454
    • MacMillan, M.L.1    Blazar, B.R.2    Defor, T.E.3
  • 17
    • 79959265855 scopus 로고    scopus 로고
    • Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency
    • Ren J, Jin P, Sabatino M, et al. Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency. Cytotherapy 2011; 13: 661-674.
    • (2011) Cytotherapy , vol.13 , pp. 661-674
    • Ren, J.1    Jin, P.2    Sabatino, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.